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Over the past century, the average age of menar-
che has declined worldwide, from 16–17 years 
to < 13 years of age (Euling et al. 2008). This 
documented trend toward a younger age of 
menarche has been observed consistently across 
socioeconomic and race/ethnicity groups (Lee 
et al. 2001; Wronka 2010) and cannot be 
attributed to increased nutritional status alone 
(Himes et al. 2009; Wang 2002).
An earlier onset of menarche is associated 
with many adverse health and social outcomes 
(Zuckerman 2001). Earlier menarche has 
been associated with increased breast cancer 
risk (Iwasaki et al. 2007; Maskarinec et al. 
2006; Stavraky and Emmons 1974), adult-
onset asthma (Al-Sahab et al. 2010; Macsali 
et al. 2011), shorter adult stature (Carel 2006; 
Partsch and Sippell 2001), hyper insulinemia 
and metabolic syndrome (Frontini et al. 
2003), type 2 diabetes (He et al. 2010), and 
reproductive tract cancers (Dossus et al. 
2010; Elwood et al. 1977; Fujita et al. 2008). 
Furthermore, decreased age of menarche has 
been associated with behavioral and psycho-
social disorders, as well as with increased risk 
of sexual abuse, depression, and teen preg-
nancy (Deardorff et al. 2005; Jacobson-
Dickman and Lee 2009; Joinson et al. 2011; 
Phinney et al. 1990).
Scientists have proposed many theories 
to explain the progressive decline in age of 
onset of menarche (Zuckerman 2001). 
No consistent relationship between age of 
 menarche and smoking status, socioeconomic 
status, family structure, or formula feeding 
has been seen (Rokade and Mane 2009). 
Another hypothe sis regarding the cause of 
earlier puberty and menarche is increased 
environmental exposure to endocrine-dis-
rupting compounds (EDCs) in household 
and personal care products (Buck Louis et al. 
2008; Chen et al. 2011; Ozen et al. 2012; 
Schell and Gallo 2010). EDCs are synthetic 
or natural compounds that can mimic, alter, 
or attenuate the action of natural hormones 
found in the body.
Several compounds to which the general 
U.S. population is regularly exposed have been 
implicated as affecting endocrine function or 
development. For example, certain benzo-
phenones, dichlorophenols, parabens, and the 
compound triclosan have been shown to dis-
rupt estrogen receptor signaling in animal and 
in vitro models either by binding directly to 
the receptor itself or through modulation of 
downstream signaling processes (Akahori et al. 
2008; Craig et al. 2011; Kawaguchi et al 2009; 
Shaw and deCatanzaro 2009; Stoker et al. 
2010; Vo et al. 2010; Yamasaki et al. 2005). 
Conversely, compounds such as phthalates and 
bisphenol A have been shown in human and 
animal studies to disrupt  androgen-dependent 
processes (Howdeshell et al. 2008; Miao et al 
2011; Svechnikov et al. 2010), with bisphe-
nol A implicated in both anti-androgenic and 
estrogenic responses (Chao et al. 2012). Each 
of these chemicals is manufactured at high 
volumes for use in household products such 
as plastic food containers, personal care prod-
ucts, and household cleaners and deodorizers, 
allowing potentially high exposures to occur 
in the general public through daily activities 
and behaviors.
Our objective was to use the 2003–2008 
National Health and Nutrition Examination 
Survey (NHANES) data to assess the potential 
association between environmental exposures 
to synthetic EDCs, as assessed by urinary bio-
markers, and age of menarche after adjusting 
for various demographic and health-related 
factors. We evaluated chemicals previously 
identified as potential endocrine disruptors 
that are found in most of the U.S. population 
and were measured in NHANES participants 
during at least 3 consecutive years.
Methods
Study population. NHANES is a cross-
 sectional, multistage, stratified, cluster sam-
pling survey conducted by the Centers for 
Disease Control and Prevention’s (CDC) 
National Center for Health Statistics. 
NHANES uses a complex sampling design 
that includes questionnaires about demo-
graphics and health-related behaviors, as 
well as laboratory and clinical measurements 
(CDC 2011). We limited our analysis to par-
ticipants between 12 and 16 years of age to 
capture exposures close to the age of menar-
che among those who completed reproductive 
heath questionnaires (administered beginning 
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Methods: We used data from female participants 12–16 years of age who had completed the repro-
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Prevention’s National Health and Nutrition Examination Survey (NHANES) for years 2003–2008 
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at age 12). Reproductive health questionnaires 
were administered through a proxy of parent 
or guardian to females 12 years of age, the 
lower age limit in our analysis, to 16 years. 
All procedures were approved by the NCHS 
Institutional Review Board, and all partici-
pants provided written informed consent. 
During 2003–2004, NHANES sampled uri-
nary phenols and phthalates in two separate 
one-third subsets, and a single one-third sub-
set was analyzed for phenols, phthalates, and 
parabens from 2005 through 2008. In each 
case, subsets were a representative sample of 
NHANES participants ≥ 6 years of age from 
each 2-year study cycle. Therefore, data pre-
sented for phenols and phthalates are from 
years 2003–2008, whereas data from parabens 
are from years 2005–2008 only. Laboratory 
samples were collected on the same day the 
questionnaire was administered.
Measurement of urinary phenols, para-
bens, and phthalates. Phenols and parabens. 
Environmental phenols considered for inclu-
sion were bisphenol A (BPA), 4-tert-octyl 
phenol, 2,4,4´-trichloro-2´-hydroxyphenyl 
ether (triclosan), 2-hydroxy-4-metoxybenzo-
phenone (benzophenone-3). Parabens consid-
ered for inclusion were propyl-, butyl-, ethyl-, 
and methyl-paraben, 2,4-dichlorophenol 
(2,4-DCP), o-phenyl phenol, 2,5-dichloro-
phenol (2,5-DCP), 2,4,5-trichlorophenol, and 
2,4,6-trichlorophenol (CDC 2011). These 
substances were quantified in urine by use of 
solid phase extraction (SPE) coupled on-line 
to high performance liquid chromatography–
tandem mass spectrometry (HPLC-MS/MS) 
(Ye et al. 2005, 2006). In addition we evalu-
ated the phenol metabolites 2,4-DCP, o-phenyl 
phenol, 2,5-DCP, 2,4,5-trichlorophenol, and 
2,4,6-trichlorophenol, which were measured 
in urine by use of SPE-HPLC followed by 
atmospheric pressure chemical ionization–
high-performance liquid chromatography–
isotope dilution tandem mass spectrometry 
(APCI-MS/MS) (Ye et al. 2005).
Phthalate  metabol i tes .  We used 
HPLC-MS/MS with electrospray ioniza-
tion to quantify the following phthalate 
metabolites in urine: monomethyl phthalate, 
monoethyl phthalate, monobutyl phthalate, 
mono-isobutyl phthalate, mono(3-carboxy-
propyl) phthalate, monocyclohexyl phthalate, 
mono(2-ethylhexyl) phthalate, monooctyl 
phthalate, monobenzyl phthalate, mono-
isononyl phthalate, mono(2-ethyl-5-oxohexyl) 
phthalate, mono(2-ethyl-5-hydroxyhexyl) 
phthalate, mono(2-ethyl-5-carboxypentyl) 
phthalate, monocarboxyoctyl phthalate, and 
monocarboxynonyl phthalate (CDC 2011).
Before analysis by HPLC-MS/MS, the urine 
samples were processed through use of enzy-
matic deconjugation of the glucuronidated 
phthalate monoesters, followed by on-line 
SPE (Kato et al. 2005; Silva et al. 2007).
Data analysis. We included female 
2003–2008 NHANES study participants 
12–16 years of age who had completed the 
reproductive health questionnaire and physi-
cal examination, and for whom data regard-
ing age of menarche, defined by NHANES as 
age of first menstruation, were available. Of 
the 1,598 individuals 12–16 years of age who 
had completed the reproductive health ques-
tionnaire, 1,420 participants had complete 
data on body mass index (BMI) and age of 
menarche (age or not yet reached). Of these, 
461 were included in NHANES subsamples 
with urinary phenol and phthalate measure-
ments. We used the one-third subsample 
weighting variables for each 2-year subset of 
data. Nonmissing values for urine concentra-
tions below the limit of detection (LOD) were 
replaced with the value of the LOD divided by 
the square root of 2. In our analysis, all urinary 
compounds and metabolites were creatinine-
corrected by dividing urine concentrations by 
creatinine concentrations to give micrograms 
per gram of creatinine as the final units. Urine 
samples with creatinine levels > 300 mg/dL or 
< 30 mg/dL were excluded because they were 
too dilute or too concentrated for accurate 
analysis (n = 11) (Sata et al. 1995).
We used SAS 9.2 for data analysis, and 
calculated means and percentiles of the EDCs 
and demographic factors by use of the PROC 
SURVEYMEANS (weighted geometric means) 
procedure to account for the complex sam-
pling design of NHANES. We calculated the 
weighted mean self-reported age of  menarche 
using PROC LIFETEST (Kaplan–Meier 
censored survival estimates) to account for 
censoring at the age of participation among 
43 individuals who had not reached menarche 
at the time of participation (all programs from 
SAS Institute Inc., Cary, NC). We used the 
Taylor series (linearization) method to estimate 
standard errors and confidence intervals. We 
calculated BMI percentile for age in months 
using the standardized CDC growth charts 
(Grummer-Strawn et al. 2010). We set signifi-
cance at α = 0.05 for two-sided p-values. 
To estimate associations between EDCs 
and age of menarche, we used the PROC 
SURVEYPHREG (Cox-proportional hazards 
model with censored data) procedure and the 
efron method of ties handling, after confirm-
ing the proportional hazards assumption. We 
modeled the natural log of creatinine-corrected 
urine analyte concentrations to normalize dis-
tributions in our data and, in accordance with 
NHANES analytic guidelines, we excluded 
10 observations with outlier values > 3 SDs 
for deviance residuals of the log-transformed 
weighted values, as determined by a prob-
ability plot of residuals (CDC 2011). These 
adjustments left a sample size of 440 for our 
phenol analysis, 437 for phthalate analysis, 
and 287 individuals for parabens analysis.
We assessed the urinary concentration of 
18 EDCs found above the LOD in at least 
75% of study participants as exposures in our 
model, out of a total of 27 phthalate, phenol, 
and pesticide compounds or metabolites evalu-
ated in urine in NHANES. These compounds 
were then analyzed either as single compounds 
(benzophenone-3, triclosan, BPA, 2,4-DCP, 
and 2,5-DCP) or as the sum of urinary analyte 
concentrations within a class of compounds 
(parabens, phthalates, and environmental phe-
nols), again including only those compounds 
found above the LOD in at least 75% of study 
participants. We converted compounds to 
molar weights for summing to adjust for the 
different molecular weights of compounds 
and used micrograms per gram of creatinine as 
the unit in our models. We identified poten-
tial confounders from the literature (moth-
er’s age at birth of girl, mother’s smoking 
status during pregnancy, birth weight < 5.5 
pounds (yes or no), birth weight > 9.0 pounds 
(yes or no), family income (1–12 categories 
based on NHANES categories of $0–4,999 
to ≥ $75,000), family income-to-poverty 
ratio (0–5), self-defined race/ethnicity, BMI 
(continuous) as calculated by measurements 
taken during the NHANES examination, 
and BMI percentile for sex and age in months 
(0–100) as calculated using CDC standard-
ized growth charts) (Grummer-Strawn et al. 
2010) and included them in our final mod-
els if they either predicted the outcome with 
p < 0.05 or there was a > 10% change in the 
hazard ratio for the exposure–menarche asso-
ciation when they were removed from the 
model. Insufficient observations existed for 
birth weight to include in model building. 
Backward and forward selection resulted in 
the same final model.
We evaluated BMI and race/ethnicity 
as effect modifiers by evaluating stratum-
specific hazard ratios because differences in 
age of menarche among ethnicities are well 
established (Himes et al. 2009). Interactions 
between race/ethnicity and urinary phenol 
concentrations were evaluated using interac-
tion terms in the model, with p < 0.10 for the 
interaction term used to evaluate significance 
of the interaction.
Results
Most participants included in our analysis 
(63.1%) were of non-Hispanic white ethnicity 
(Table 1). Of the 342 with complete informa-
tion on mother’s smoking status, 13.9% had 
mothers who smoked during pregnancy. The 
mean family income-to-poverty ratio was 2.6 
[95% confidence interval (CI): 2.4, 2.7], the 
mean mother’s age at the participant’s birth 
was 26.8 years (95% CI: 26.3, 27.3), the mean 
BMI was 22.8 (95% CI: 22.2, 23.4), and the 
average age of menarche was 12.0 years (95% 
CI: 11.8, 12.1). Age of menarche ranged from 
Age of menarche and endocrine disruptors
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8 to 16 years, with 43 individuals not having 
attained menarche by the time of survey.
Mean BMI was higher among non-
 Hispanic black girls than among non- Hispanic 
white girls and girls of other, multiracial eth-
nicities (Table 2). The mean age of menarche 
was significantly lower among non- Hispanic 
black adolescent girls than among non-
 Hispanic white adolescent girls.
Three phenols, BPA, benzophenone-3, 
and triclosan, were each above the LOD 
in at least 75% of study participants and 
were evaluated as single compounds in our 
analysis. The parabens propyl paraben and 
methyl paraben were above the LOD in at 
least 75% of study participants and were 
summed as total parabens for analysis. The 
phthalate metabolites monoethyl phthalate, 
monobutyl phthalate, mono-isobutyl phtha-
late, mono(3-carboxypropyl) phthalate, 
mono(2-ethylhexyl) phthalate, mono benzyl 
phthalate,  mono(2-ethyl-5-oxohexyl) 
phthalate, mono(2-ethyl-5-hydroxyhexyl) 
phthalate, mono(2-ethyl-5-carboxypentyl) 
phthalate, monocarboxyoctyl phthalate, and 
mono carboxynonyl phthalate were above the 
LOD in at least 75% of study participants 
and were summed as total phthalates for anal-
ysis. The phenol metabolites 2,4-DCP and 
2,5-DCP were above the LOD in 99.8% and 
91.8% of study participants, respectively, and 
were evaluated both as separate compounds 
and summed as total phenol metabolites. 
Geometric means and 95% CIs of urinary 
creatinine-adjusted EDC levels are reported 
in Table 3.
Consistent with observations from the com-
plete NHANES data set, the mean environ-
mental phenol concentration differed by 
race/ethnicity, with non- Hispanic white girls 
(n = 124; mean = 7.07 µg/g; 95% CI: 5.53, 
9.03) having statistically significantly lower 
environmental phenol concentrations than non-
 Hispanic black (n = 136, mean = 26.8 µg/L; 
95% CI: 17.0, 42.0) on the basis of nonover-
lapping CIs (Table 3). Concentrations of other 
compounds did not differ significantly by race/
ethnicity (data not shown).
Family income-to-poverty ratio, mother’s 
age at the participant’s birth, and the mother’s 
smoking status during pregnancy were not 
retained in our model because they were not 
significant predictors of menarche.
Total parabens, BPA, triclosan, benzophe-
none-3, and total phthalates were not signifi-
cantly associated with age of menarche, either 
before or after adjustment for BMI and race/
ethnicity (Table 4). However, a 1-unit increase 
in log-transformed creatinine-corrected urine 
phenol concentration was associated with a 
0.7-month decrease in average age of menar-
che (adjusted hazard ratio = 1.10; 95% CI: 
1.02, 1.20; p = 0.01). 2,5-DCP was the only 
individual compound that was significantly asso-
ciated with age of menarche (adjusted hazard 
ratio = 1.10; 95% CI: 1.01, 1.19; p = 0.025). 
The association (hazard ratios) between urinary 
2,5-DCP or total environmental phenol con-
centration and age of menarche did not differ by 
race/ethnicity (data not shown).
When we considered the total environ-
mental phenol concentration for adolescent 
girls above the 75th percentile, the average 
age of menarche was 11.8 years (95% CI: 
11.6, 12.0). In comparison, the average age 
of menarche for adolescent girls below the 
25th percentile of total environmental phenol 
urine concentration was 12.4 years (95% CI: 
12.2, 12.6) (Table 5).
Discussion
Levels of urinary EDCs in our study popula-
tion were comparable to levels reported in 
the 6–11 and 12–19 years age groups in the 
Table 1. Descriptive statistics for age at menarche and selected covariates among girls 12–16 years of 




Weighted percenta or 
mean value (95% CI)
Race/ethnicity (%) 
Non-Hispanic white 124 63.1 (55.4, 70.7)
Non-Hispanic black 135 14.6 (10.8, 18.4) 
Mexican American 135 11.9 (8.1, 15.7) 
Other Hispanic 25 5.2 (2.3, 8.2) 
Other, multiracial 21 5.2 (2.3, 8.1)
Smoking status of mother during pregnancy (%) 
Yes 33 13.9 (8.9, 18.5) 
No 309 86.1 (81.5, 91.1)
Family income-to-poverty ratio 440 2.6 (2.4, 2.7)
Mother’s age at participant’s birth (years) 347 26.8 (26.3, 27.3)
Self-reported age at menarche (years) 440 12.0 (11.8, 12.1)
BMI (kg/m2)b 440 22.8 (22.2, 23.4)
aEstimated percent distribution (95% CI) after applying NHANES sampling weights. bBMI as measured by the mobile 
examination clinic personnel.
Table 2. Weighted mean BMI and self-reported age of menarche by race/ethnicity among girls 








age of menarchea 
(95% CI)
Non-Hispanic white 124 22.1 (21.3, 22.9) 59.6 (53.6, 65.6) 12.1 (11.9, 12.3)
Non-Hispanic black 135 25.5 (24.7, 26.4) 76.6 (72.2, 81.0) 11.5 (11.3, 11.7)
Mexican American 135 23.2 (21.9, 24.4) 67.6 (62.2, 73.0) 11.8 (11.6, 12.0)
Other Hispanic 25 25.2 (22.4, 28.0) 77.0 (62.2, 91.9) 11.4 (10.7, 12.1)
Other, multi-racial 21 19.9 (18.1, 21.7) 48.5 (34.3, 64.7) 11.9 (11.7, 12.2)
Total 440 22.8 (22.2, 23.4) 63.3 (59.2, 67.5) 12.0 (11.8, 12.1)
aAge of menarche is self-reported as age in years of first menstrual period.
Table 3. Estimated creatinine-corrected weighted geometric means (µg/g creatinine) of selected EDCs and EDC metabolites among girls 12–16 years of age in 
NHANES 2003–2008 by race/ethnicity.
Analyte
Geometric mean (µg/g) (95% CI)
Non-Hispanic  








(n = 21) Total (n = 440)
BPA (n = 440) 2.47 (2.14, 2.86) 2.22 (1.91, 2.57) 1.85 (1.5, 2.2) 1.48 (1.20, 1.84) 1.80 (1.23, 2.64) 2.25 (2.02, 2.52)
Benzophenone-3 (n = 440) 36.5 (24.3, 54.8) 12.3 (9.62, 15.7) 18.7 (14.3, 24.4) 18.7 (10.0, 34.8) 27.4 (11.1, 67.7) 27.4 (21.6, 36.8)
Triclosan (n = 440) 13.6-(8.44, 21.9) 6.92 (4.89, 9.80) 10.3 (6.44, 16.6) 9.48 (3.92, 22.9) 47.4 (10.1, 223) 12.4 (8.98, 17.2)
Total parabensa (n = 287) 593 (410, 858) 1,360 (1,030, 1,790) 859 (637, 1,157) 277 (161, 476) 535 (179, 1,600) 668 (527, 847)
Total phthalate metabolitesb (n = 437) 1.61 (1.35, 1.92) 1.76 (1.48, 2.10) 1.89 (1.57, 2.29) 1.99 (1.48, 2.67) 1.57 (1.20, 2.06) 1.68 (1.49, 1.90)
2,4-DCP (n = 440) 0.637 (0.520, 0.787) 1.15 (0.850, 1.55) 1.21 (0.90, 1.62) 0.678 (0.380, 1.22) 0.927 (0.550, 1.57) 0.766 (0.660, 0.890)
2,5-DCP (n = 440) 5.89 (4.55, 7.62) 25.0 (15.7, 39.7) 19.6 (12.3, 31.1) 13.3 (6.54, 27.1) 14.7 (7.20, 30.2) 9.18 (7.49, 11.3)
Total phenol metabolitesc (n = 440) 7.07 (5.53, 9.03) 26.8 (17.0, 42.0) 21.7 (13.9, 33.7) 14.8 (7.46, 29.4) 16.1 (8.13, 31.9) 10.6 (8.78, 12.9)
aTotal parabens include propyl paraben and methyl paraben. bTotal phthalate metabolites include phthalate metabolites monoethyl phthalate, monobutyl phthalate, mono-isobutyl 
phthalate, mono(3-carboxypropyl) phthalate, mono(2-ethylhexyl) phthalate, monobenzyl phthalate, mono(2-ethyl-5-oxohexyl) phthalate, mono(2-ethyl-5-hydroxyhexyl) phthalate, 
mono(2-ethyl-5-carboxypentyl) phthalate, monocarboxyoctyl phthalate, and monocarboxynonyl phthalate. cTotal phenol metabolites include 2,4-DCP and 2,5-DCP.
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overall 2005–2008 NHANES population 
(CDC 2011).
A significant, inverse relationship was seen 
between age of menarche and urinary envi-
ronmental phenols and 2,5-DCP. Girls with 
urinary environmental phenol concentrations 
above the 75th percentile had a significantly 
lower age of menarche than girls below the 
75th percentile. No other significant associa-
tions were seen between urinary EDC bio-
markers and age of menarche. The difference in 
age of menarche between those in the highest 
percentile of exposure and those in the lowest 
percentile of exposure was small and may not 
be clinically significant, but if the association 
was causal it suggests a physiologic effect.
We found an association between 
2,5-DCP, as assessed by urinary biomark-
ers, and age of menarche in a representa-
tive sample of the U.S. population. Another 
cross-sectional study reported an association 
between serum PBDEs (polybrominated 
diphenyl ethers) and age of menarche in ado-
lescent girls (Chen et al. 2011). Three cohort 
studies have examined relationships between 
EDC biomarkers and early menarche. A 
study of 151 women living in the Great Lakes 
region of the United States reported an asso-
ciation between in utero exposure to the DDT 
(dichlorodiphenyltrichloroethane) metabolite 
DDE (dichlorodiphenyldichloroethylene) and 
early menarche (Vasiliu et al. 2004). Among 
a cohort of Michigan women exposed to poly-
brominated biphenyl (PBB) flame retardants 
from contaminated dairy and beef there was an 
association between in utero PBB exposure and 
early menarche among their female children 
(Blanck et al. 2000). In a retrospective study, 
serum DDT levels were associated with early 
puberty in a retrospective cohort study of chil-
dren in Belgium, but the association was lim-
ited to 145 children who were born outside of 
Belgium, and confounding by factors related 
to place of birth or related factors could not 
be ruled out (Krstevska-Konstantinova et al. 
2001). Blood lead levels have been associated 
with delayed puberty in boys and girls (Hauser 
et al. 2008; Selevan et al. 2003), and exposures 
to dioxins have been associated with delayed 
puberty in boys (Korrick et al. 2011).
2,5-DCP is the major metabolite of 
dichlorobenzene (DCB), a common fumi-
gant also used in mothballs, insect repellants, 
deodorizers, and toilet bowl disinfectants. 
2,5-DCP can be used to estimate exposure to 
the putative endocrine disruptor DCB in the 
previous 6–12 months, which is particularly 
important when interpreting an end point 
such as age of menarche that is dependent 
on earlier changes in the neuroendocrine axis 
of the brain (Teitelbaum et al. 2008). DCB 
is found in drinking water at concentrations 
up to 1 mg/L and in food at levels up to 
10 mg/kg (Barber et al. 2009). The U.S. popu-
lation was exposed to a nearly constant level of 
25 µg/m3 DCB in indoor air, according to a 
longitudinal study of homes in 1987 (Wallace 
1991a, 1991b; Wallace and Pellizzari 1995), 
and, although air concentrations may have 
declined since these studies, DCB was still 
readily detected in amniotic fluid (Bradman 
et al. 2003) and human breast milk at concen-
trations of 5–30 mg/kg nearly 20 years after 
the indoor air study (Ye et al. 2006).
Like benzophenones, phenols, and 
parabens, DCB has been reported to have 
both in vitro EDC activity and EDC effects 
in laboratory animals [Darbre and Harvey 
2008; Fang et al. 2000; Hershberger et al. 
2005; Makita 2008; Marsman 1995; Molina-
Molina et al. 2008; National Toxicology 
Program (NTP) 2008; Takahashi et al. 2011; 
Versonnen et al. 2003]. The levels of DCB 
at which EDC activity was evident were 
consistent with levels observed for human 
daily exposures as well as at higher levels of 
exposure. DCB has been associated with low 
birth weight and low maternal weight gain in 
rats (Marsman 1995) and sperm abnormali-
ties in male mice and rats (Takahashi et al. 
2011). In a study of 404 pregnant women, 
urinary levels of 2,5-DCP during the third 
trimester of pregnancy were associated with 
low birth weight and length in male humans 
(Wolff et al. 2008). DCB is hepatotoxic and 
hepatocarcinogenic to rats and mice (NTP 
1987, 2002), and it reduces plasma levels of 
thyroxine in rats (den Besten et al. 1991). 
DCB is currently undergoing tier 1 testing 
for endocrine-disrupting potential by the U.S. 
Environmental Protection Agency (2010).
The present study has several limitations. 
First, questionnaire data are self-reported and 
may be subject to misclassification. Second, 
we cannot rule out potential confounding 
by unmeasured factors associated with DCB 
exposure and the timing of puberty and 
menarche. In addition, exposures were mea-
sured at a single point in time after the onset 
of menarche in all but 43 participants; ideally, 
we would measure urinary EDCs several times 
during the 6–36 months before menarche, 
and adjust for BMI before menarche only. 
Age of menarche was recorded as age in years 
at first menstrual period. This limitation is 
further complicated by the half-life of these 
Table 4. Weighted survival analysis model estimates and parameters of time of menarche and log creatinine-corrected urinary concentrations (µg/g creatinine) 
of potential EDCs among girls 12–16 years of age in NHANES 2003–2008 participating in the reproductive health questionnaire and environmental phenol labora-
tory analysis.
Parameter Pr > |t |a
Unadjusted HR  
(95% CI)
HR adjusted for 
race/ethnicity 
(95% CI)
HR adjusted for 
BMI and race/ethnicity 
(95% CI)
HR adjusted for  
BMI percentile and race/ethnicity 
(95% CI)
Total parabensb (n = 287) 0.47 1.06 (0.94, 1.18) 1.04 (0.92, 1.17) 0.96 (0.84, 1.09) 1.05 (0.93, 1.19)
BPA (n = 441) 0.50 0.93 (0.78, 1.11) 0.97 (0.82, 1.15) 0.94 (0.79, 1.13) 0.94 (0.80, 1.10)
Triclosan (n = 440) 0.50 0.96 (0.88, 1.04) 0.96 (0.90, 1.04) 0.97 (0.90, 1.05) 1.0 (0.91, 1.09)
Benzophenone-3 (n = 440) 0.62 0.95 (0.88, 1.02) 0.98 (0.90, 1.06) 0.98 (0.89, 1.07) 0.99 (0.91, 1.08)
Total phthalatesc (n = 437) 0.39 0.92 (0.79, 1.08) 0.91 (0.77, 1.07) 0.95 (0.85, 1.07) 0.98 (0.86, 1.12)
Total environmental phenold (n = 440) 0.017 1.10 (1.02, 1.18) 1.07 (0.99, 1.16) 1.10 (1.02, 1.20) 1.10 (1.01, 1.19)
2,5-DCP (n = 440) 0.025 1.15 (1.07, 1.23) 1.13 (1.04, 1.23) 1.10 (1.01, 1.19) 1.09 (1.01, 1.19)
2,4-DCP (n = 440) 0.066 1.06 (0.98, 1.15) 1.04 (0.96, 1.12) 1.08 (0.99, 1.18) 1.02 (0.94, 1.13)
HR, hazard ratio.
aModel was adjusted by BMI and race/ethinicity. bTotal parabens includes propyl paraben and methyl paraben. cTotal phthalate metabolites include phthalate metabolites monoethyl 
phthalate, monobutyl phthalate, mono-isobutyl phthalate, mono (3-carboxypropyl) phthalate, mono(2-ethylhexyl) phthalate, monobenzyl phthalate, mono(2-ethyl-5-oxohexyl) phthalate, 
mono(2-ethyl-5-hydroxyhexyl) phthalate, mono(2-ethyl-5-carboxypentyl) phthalate, monocarboxyoctyl phthalate, and monocarboxynonyl phthalate. dTotal phenol metabolites include 
2,4-DCP and 2,5-DCP.
Table 5. Weighted mean self-reported age of menarche by percentile of creatinine-corrected urinary 
environmental phenol concentration in girls 12–16 years of age in NHANES 2003–2008 (n = 440).
Percentile of phenol 
concentration of study 
participantsa
Weighted geometric mean 
creatinine-corrected 
total phenol concentration 
(µg/g creatinine) (95%CI)
Weighted geometric mean 
creatinine-corrected  
2,5-DCP concentration  
(µg/g creatinine) (95%CI)
Weighted mean 
age (years) of 
menarche  
(95% CI)
< 25th 2.36 (2.14, 2.60) 3.21 (2.84, 3.63) 12.4 (12.2, 12.6)
25th– < 50th 7.39 (6.74, 8.10) 8.06 (6.95, 9.34) 12.2 (12.0, 12.4)
50th < 75th 26.7 (24.3, 29.8) 27.5 (23.2, 32.4) 11.7 (11.5, 11.9)
≥ 75th 207 (156, 275) 196 (142, 270) 11.8 (11.6, 12.0)
aPercentiles determined based on total phenol concentration.
Age of menarche and endocrine disruptors
Environmental Health Perspectives • volume 120 | number 11 | November 2012 1617
compounds. Although the U.S. population is 
continuously exposed to compounds such as 
BPA, dichlorophenols, and certain phthalates, 
resulting in relatively constant levels of these 
compounds in serum and urine (CDC 2011), 
the relatively short half-lives of these com-
pounds limits our ability to predict exposures 
before menarche using a single urine sample. 
Differences in urine 2,5-DCP concentrations 
also may reflect differences in metabolism, 
rather than direct differences in individual 
exposures. Finally, we cannot rule out chance 
findings due to multiple comparisons, and it is 
possible that the association between 2,5-DCP 
and decreased age of menarche could reflect 
changes in personal habits, pharmacokinetics, 
or metabolism after menarche.
Conclusions
We estimated an inverse association between 
urinary 2,5-DCP concentration and age of 
menarche in girls 12–16 years of age who 
participated in the NHANES study during 
2003–2008. To our knowledge, ours is the 
first population-based study to report an asso-
ciation between exposure to the putative envi-
ronmental EDC dichlorobenzene and age 
of menarche, an outcome that may reflect 
 endocrine-disrupting effects. Although this 
finding must be interpreted with caution 
given study limitations, it highlights the need 
for more research into the potential role of 
environmental exposures to potential EDCs 
and adverse endocrine and reproductive 
health outcomes in humans.
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